Global cancer immunotherapy sales share by type 2021 forecast
This statistic depicts the market share forecast for top immuno-oncology companies worldwide in 2021. By 2021, it is predicted that Bristol-Myers Squibb will account for 34 percent of immuno-oncology sales worldwide.